These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1977621)

  • 1. Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.
    Daly M; Bruce D; Perry DJ; Price J; Harper PL; O'Meara A; Carrell RW
    FEBS Lett; 1990 Oct; 273(1-2):87-90. PubMed ID: 1977621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site.
    Brennan SO; Myles T; Peach RJ; Donaldson D; George PM
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):26-30. PubMed ID: 2104980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity.
    Blajchman MA; Fernandez-Rachubinski F; Sheffield WP; Austin RC; Schulman S
    Blood; 1992 Mar; 79(6):1428-34. PubMed ID: 1547341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III-Amiens: a new family with an Arg47----Cys inherited variant of antithrombin III with impaired heparin cofactor activity.
    Roussel B; Dieval J; Delobel J; Fernandez-Rachubinski F; Eng B; Rachubinski RA; Blajchman MA
    Am J Hematol; 1991 Jan; 36(1):25-9. PubMed ID: 1984678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F.
    Olds RJ; Lane DA; Boisclair M; Sas G; Bock SC; Thein SL
    FEBS Lett; 1992 Apr; 300(3):241-6. PubMed ID: 1555650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III Kumamoto: identification of a point mutation and genotype analysis of the family.
    Ueyama H; Murakami T; Nishiguchi S; Maeda S; Hashimoto Y; Okajima K; Shimada K; Araki S
    Thromb Haemost; 1990 Apr; 63(2):231-4. PubMed ID: 2194315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III Padua 2: a single base substitution in exon 2 detected with PCR and direct genomic sequencing.
    Olds RJ; Lane DA; Caso R; Girolami A; Thein SL
    Nucleic Acids Res; 1990 Apr; 18(7):1926. PubMed ID: 2336381
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI.
    Gandrille S; Vidaud D; Emmerich J; Clauser E; Sié P; Fiessinger JN; Alhenc-Gelas M; Priollet P; Aiach M
    Br J Haematol; 1991 Jul; 78(3):414-20. PubMed ID: 1873224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
    Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V
    Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reaction.
    Perry DJ; Harper PL; Fairham S; Daly M; Carrell RW
    FEBS Lett; 1989 Aug; 254(1-2):174-6. PubMed ID: 2776881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate.
    Caso R; Lane DA; Thompson EA; Olds RJ; Thein SL; Panico M; Blench I; Morris HR; Freyssinet JM; Aiach M
    Br J Haematol; 1991 Jan; 77(1):87-92. PubMed ID: 1998601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel amino acid substitution in the reactive site of a congenital variant antithrombin. Antithrombin pescara, ARG393 to pro, caused by a CGT to CCT mutation.
    Lane DA; Erdjument H; Thompson E; Panico M; Di Marzo V; Morris HR; Leone G; De Stefano V; Thein SL
    J Biol Chem; 1989 Jun; 264(17):10200-4. PubMed ID: 2722864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the site of signal peptidase cleavage in normal and variant human preproalbumin.
    Peach RJ; Boswell DR; Brennan SO
    Protein Seq Data Anal; 1991 Aug; 4(2):123-6. PubMed ID: 1946330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for antithrombin III type I deficiency: three novel mutations located in exon IV.
    Vidaud D; Emmerich J; Sirieix ME; Sié P; Alhenc-Gelas M; Aiach M
    Blood; 1991 Nov; 78(9):2305-9. PubMed ID: 1932746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.
    Bock SC; Marrinan JA; Radziejewska E
    Biochemistry; 1988 Aug; 27(16):6171-8. PubMed ID: 3191114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of the reactive center (serine 394) of antithrombin III.
    Stephens AW; Siddiqui A; Hirs CH
    J Biol Chem; 1988 Nov; 263(31):15849-52. PubMed ID: 3141397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hb Trollhättan [beta 20(B2)Val-->Glu]--a new haemoglobin variant with increased oxygen affinity causing erythrocytosis.
    Landin B; Berglund S; Lindoff B
    Eur J Haematol; 1994 Jul; 53(1):21-5. PubMed ID: 7914875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.
    Picard V; Ersdal-Badju E; Bock SC
    Biochemistry; 1995 Jul; 34(26):8433-40. PubMed ID: 7599134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.